Sage Journals: Discover world-class research

Retricted access

Research article

First published 2003-9

Long-Acting Inhaled β 2 -Agonists for Stable COPD

John A Dougherty, Bethany L Didur, Loutfi S Aboussouan

Annals of Pharmacotherapy

Retricted access

Research article

First published 2010-10

FDA's Recommendations on the Use of Long-Acting β 2 Agonists in the Management of Asthma

Christie A Robinson

Annals of Pharmacotherapy

Retricted access

Review article

First published 2017-8

Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease

Sarah E. Petite

Annals of Pharmacotherapy

Retricted access

Research article

First published 2008-06

Management of Exercise-Induced Bronchospasm in Children:Role of Long-Acting β 2 -Adrenergic Receptor Agonists

Henry Milgrom, Robert J. Dockhorn

Pediatric Allergy,Immunology,and Pulmonology

Retricted access

Research article

First published 2017-11

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β 2 -Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid

Jennifer C. Samp, Min J. Joo, Glen T. Schumock [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2013-10

Comparison of the bronchodilator and systemic effects of AZD3199,an inhaled ultra-long-acting β 2 -adrenoceptor agonist,with formoterol in patients with asthma

Leif Bjermer, Johan Rosenborg, Thomas Bengtsson [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2024

Long-acting muscarinic antagonist and long-acting β 2 -agonist combination for the treatment of maintenance therapy–naïve patients with chronic obstructive pulmonary disease: a narrative review

Roland Buhl, Marc Miravitlles, Antonio Anzueto [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Letter

First published 2004-3

Correction: Long-acting inhaled β 2 -agonists for stable COPD

John A Dougherty

Annals of Pharmacotherapy

Free access

Review article

First published 2011-10

Profiling the bronchodilator effects of the novel ultra-long-acting β 2 -agonist indacaterol against established treatments in chronic obstructive pulmonary disease

Claus Vogelmeier, Helgo Magnussen, Craig LaForce [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2015-06

A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β 2 -Agonists

Ole D. Wolthers, Tushar Shah

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Search results